Invest in Landos Biopharma on Stash

Landos Biopharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. The Company through its artificial intelligence (AI)-based precision medicine platform, LANCE platform, identifies novel therapeutic targets based on predictions of immunometabolic function and create therapeutic candidates to engage those targets in areas of unmet medical need. It identifies novel immunometabolic targets and product candidates to date across indications such as ulcerative colitis (UC), Crohn’s disease (CD), lupus, rheumatoid arthritis, nonalcoholic steatohepatitis (NASH), multiple sclerosis, Alzheimer’s disease, asthma, psoriasis, atopic dermatitis, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), diabetic nephropathy and type 1 diabetes. Its clinical asset, BT-11, is a locally acting small molecule targeting inflammatory bowel disease (IBD).

To buy fractional shares

of Landos Biopharma stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Landos Biopharma

Ticker: LABP

Landos Biopharma

$1.08

+16.13%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

LABP Performance Breakdown

Share Price

$1.08

Today's change

-12.2%

Year to date change (YTD)

-79.31%

Dividend yield

N/A

Last dividend paid

N/A

Last dividend pay date

N/A

About LABP

Landos Biopharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. The Company through its artificial intelligence (AI)-based precision medicine platform, LANCE platform, identifies novel therapeutic targets based on predictions of immunometabolic function and create therapeutic candidates to engage those targets in areas of unmet medical need. It identifies novel immunometabolic targets and product candidates to date across indications such as ulcerative colitis (UC), Crohn’s disease (CD), lupus, rheumatoid arthritis, nonalcoholic steatohepatitis (NASH), multiple sclerosis, Alzheimer’s disease, asthma, psoriasis, atopic dermatitis, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), diabetic nephropathy and type 1 diabetes. Its clinical asset, BT-11, is a locally acting small molecule targeting inflammatory bowel disease (IBD).

Landos Biopharma Stock Ticker

LABP

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Certain companies are volatile.

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Landos Biopharma stock news

This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,8 recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.1

Learn how to invest

Get professional advice and education at every step.

How to buy Landos Biopharma stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash offers two subscription plans: Stash Growth and Stash+.

Once your market order of Landos Biopharma stock is complete, you'll officially be a shareholder of Landos Biopharma!

Invest in Landos Biopharma on Stash

Landos Biopharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. The Company through its artificial intelligence (AI)-based precision medicine platform, LANCE platform, identifies novel therapeutic targets based on predictions of immunometabolic function and create therapeutic candidates to engage those targets in areas of unmet medical need. It identifies novel immunometabolic targets and product candidates to date across indications such as ulcerative colitis (UC), Crohn’s disease (CD), lupus, rheumatoid arthritis, nonalcoholic steatohepatitis (NASH), multiple sclerosis, Alzheimer’s disease, asthma, psoriasis, atopic dermatitis, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), diabetic nephropathy and type 1 diabetes. Its clinical asset, BT-11, is a locally acting small molecule targeting inflammatory bowel disease (IBD).

To buy fractional shares

of Landos Biopharma stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Subscribe to The Wallet!

Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!

By using this website you agree to our Terms of Use and Privacy Policy.

Ready to start
building wealth?

By using this website you agree to our Terms of Use and Privacy Policy.